Evaluating COVID-19 vaccine effectiveness during pre-Delta, Delta and Omicron dominant periods among pregnant people in the U.S.: Retrospective cohort analysis from a nationally sampled cohort in National COVID Collaborative Cohort (N3C)

BMJ Public Health, Год журнала: 2024, Номер 2(1), С. e000770 - e000770

Опубликована: Июнь 1, 2024

To evaluate the effectiveness of COVID-19 vaccinations (initial and booster) during pre-Delta, Delta, Omicron dominant periods among pregnant people via (1) incident severe infections who were vaccinated vs. unvaccinated (2) post-COVID-19 vaccination breakthrough females non-pregnant.

Язык: Английский

Safety of COVID-19 Vaccination in Pregnancy: A Systematic Review

Diagnostics, Год журнала: 2024, Номер 14(16), С. 1775 - 1775

Опубликована: Авг. 14, 2024

The COVID-19 pandemic has posed significant risks to pregnant women and those recently pregnant, leading heightened mortality morbidity rates. Vaccination emerged as a pivotal strategy in reducing COVID-19-related deaths illnesses worldwide. However, the initial exclusion of individuals from most clinical trials raised concerns about vaccine safety this population, contributing hesitancy. This review aims consolidate existing literature assess efficacy vaccination populations neonatal outcomes. Diverse studies were included evaluating various aspects for their newborns, encompassing mild severe symptoms across different vaccines. findings indicate overall vaccination, with minimal adverse outcomes observed, including side effects like pain fever. Although reported absence outcomes, isolated case reports have potential associations between maternal conditions such fetal supraventricular tachycardia immune-mediated diseases. Our underscores importance ongoing surveillance monitoring ensure women. Overall, during pregnancy remains safe effective strategy, emphasizing need continued research vigilance safeguard health.

Язык: Английский

Establishment and validation of a prognostic model based on common laboratory indicators for SARS-CoV-2 infection in Chinese population

Annals of Medicine, Год журнала: 2024, Номер 56(1)

Опубликована: Сен. 6, 2024

At the beginning of December 2022, Chinese government made major adjustments to epidemic prevention and control measures. The infection data laboratory makers for infected patients based on this period may help with management prognostication COVID-19 patients.

Язык: Английский